ÂÜÀòÂÒÂ×

Lazaros Lataniotis is a Senior Scientist at Sana Biotechnology, Inc. since April 2022 and a Review Editor for Cardiovascular Genetics and Systems Medicine at Frontiers since May 2020. Previous positions include Postdoctoral Researcher at the University of California, San Francisco from March 2020 to April 2022, and Postdoctoral Scholar at Gladstone Institutes from October 2018 to March 2020. Lazaros completed a PhD at King's College London, focusing on genome editing and miRNA inhibition using CRISPR/Cas9, and held the role of Genomic Data Analyst at Queen Mary University of London. Early research experience includes a Master's degree in Female Reproduction from Ethnikon kai Kapodistriakon Panepistimion Athinon, where research centered on endometriosis and other genetic disorders. Professional skills encompass R programming, Linux, and statistical analysis related to genome-wide association studies (GWAS).